VT News

Robbie Brightwell

Ask VT AI
View News Summary
  • Trump meets with Syrian leader al-Sharaa, signaling a potential shift in US policy toward Syria.
  • Exelixis and Ensysce report strong biotech advances, with Exelixis' cancer drug Cabometyx driving revenue growth and Ensysce's opioid-use-disorder drug PF9001 showing promise.
  • China criticizes UK-US trade deal aimed at excluding Chinese goods from British supply chains.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Trump meets with Syrian leader al-Sharaa, signaling a potential shift in US policy toward Syria.
  • Exelixis and Ensysce report strong biotech advances, with Exelixis' cancer drug Cabometyx driving revenue growth and Ensysce's opioid-use-disorder drug PF9001 showing promise.
  • China criticizes UK-US trade deal aimed at excluding Chinese goods from British supply chains.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Robbie Brightwell

Top Topics

Trending in U.S.

World

Sport